Cargando…
Humanized liver mouse model with transplanted human hepatocytes from patients with ornithine transcarbamylase deficiency
Ornithine transcarbamylase deficiency (OTCD) is a metabolic and genetic disease caused by dysfunction of the hepatocytic urea cycle. To develop new drugs or therapies for OTCD, it is ideal to use models that are more closely related to human metabolism and pathology. Primary human hepatocytes (HHs)...
Autores principales: | Sugahara, Go, Yamasaki, Chihiro, Yanagi, Ami, Furukawa, Suzue, Ogawa, Yuko, Fukuda, Akinari, Enosawa, Shin, Umezawa, Akihiro, Ishida, Yuji, Tateno, Chise |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247293/ https://www.ncbi.nlm.nih.gov/pubmed/33336822 http://dx.doi.org/10.1002/jimd.12347 |
Ejemplares similares
-
Detection of acute toxicity of aflatoxin B1 to human hepatocytes in vitro and in vivo using chimeric mice with humanized livers
por: Ishida, Yuji, et al.
Publicado: (2020) -
Characterization and Treatment Responsiveness of Genetically Engineered Ornithine Transcarbamylase-Deficient Pig
por: Enosawa, Shin, et al.
Publicado: (2021) -
Estimating Drug Efficacy with a Diet-Induced NASH Model in Chimeric Mice with Humanized Livers
por: Kisoh, Keishi, et al.
Publicado: (2021) -
Culture density contributes to hepatic functions of fresh human hepatocytes isolated from chimeric mice with humanized livers: Novel, long-term, functional two-dimensional in vitro tool for developing new drugs
por: Yamasaki, Chihiro, et al.
Publicado: (2020) -
Antepartum Ornithine Transcarbamylase Deficiency
por: Nakajima, Hitoshi, et al.
Publicado: (2014)